Changes in LDL density across the menopausal transition

Journal of Investigative Medicine

Volumn 48, Issue 4, 2000, Pages 245-250

  Carr, M C ^a   Kim, K H ^a   Zambon, A ^a   Mitchell, E S ^a   Woods, N F ^a   Casazza, C P ^a   Purnell, J Q ^a   Hokanson, J E ^a   Brunzell, J D ^a   Schwartz, R S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cholesterol; LDL density; Lipoprotein; Menopausal transition

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; ESTROGEN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DENSITY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SYNTHESIS; MENOPAUSE; NORMAL HUMAN; PARTICLE SIZE; POSTMENOPAUSE; PREMENOPAUSE;

EID: 0033783084     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Menopause and risk of cardiovascular disease: The Framingham study
2. Some atherogenic concomitants of menopause: The Framingham Study
3. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
4. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women
5. Menopause and risk factors for coronary heart disease
6. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes
7. Low-density lipoprotein subclass patterns and risk of myocardial infarction
8. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B
9. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
10. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease
11. Low density lipoprotein particle size and coronary artery disease
12. Association of plasma triglyceride and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women
13. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk
14. Inheritance of low density lipoprotein subclass patterns: Results of complex segregation analysis
15. Genetics of LDL subclass phenotypes
16. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study
17. Symptom experiences of midlife women: Observations from the Seattle Midlife Women's Health Study
18. Preparative and quantitative isolation of plasma lipoproteins: Rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor
19. Measurement and clinical significance of low-density lipoprotein subclasses
20. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease
21. Enzymatic methods for quantification of lipoprotein lipids
22. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B
23. Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women
24. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
25. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis
26. Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein cholesterol
27. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women
28. Variation of postheparin plasma hepatic lipase by menstrual cycle
29. Different effects of continuous oestrogen-progestin and transdermal oestrogen with cyclic progestin regimens on low-density lipoprotein subclasses
30. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women
31. High density lipoprotein-2 and hepatic lipase: Reciprocal changes produced by estrogen and norgestrel
32. Small, dense LDL is associated with low lipoprotein lipase and high hepatic lipase activities, and alterations in IDL and VLDL composition
33. Evidence for a new pathophysiological mechanism for coronary artery disease regression: Hepatic lipase-mediated changes in LDL density
34. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women
35. Changes in energy balance and body composition at menopause: A controlled longitudinal study
36. Sex- and menopause-associated changes in body-fat distribution
37. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women
38. LDL subclass phenotypes and the insulin resistance syndrome in women
39. The visceral adiposity syndrome in Japanese-American men
40. Human low density lipoprotein subfractions separated by gradient gel electrophoresis: Composition, distribution, and alterations induced by cholesteryl ester transfer protein
41. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia
42. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) research group
43. A prospective study of postmenopausal estrogen therapy and coronary heart disease
44. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study